Dai-ichi Life corrects share repurchase program period

Dai-ichi Life Holdings, Inc. announced a partial correction to its previously disclosed notices concerning the status of the company's share repurchase program. The correction primarily pertains to the "Period of repurchase of shares," which was initially stated as "From May 16, 2025 to May 31, 2026" in announcements made between June 2, 2025, and November 4, 2025. The corrected period for share repurchases is "From May 16, 2025 to March 31, 2026." The company expressed apologies for any inconvenience and concern caused to shareholders, investors, and other concerned parties.

The underlying resolution for the share repurchase, approved by the board of directors on May 15, 2025, remains consistent in its other details. This includes the class of shares to be repurchased as common stock, an aggregate number of up to 200,000,000 shares (5.40% of the total issued and outstanding shares excluding treasury stock), and an aggregate price of up to JPY 100 bn. The method of repurchase is specified as open-market repurchase by the discretionary trading method.

The cumulative share repurchases made by October 31, 2025, remain unchanged, totaling 43,786,100 shares at an aggregate purchase price of JPY 49,999,915,700. The correction clarifies the intended duration of the repurchase program, aligning all past notices with the correct end date of March 31, 2026.